ArticlePharmacoepidemiology and drug safety2025

Effectiveness of Additional Risk Minimization Measures Related to Interstitial Lung Disease/Pneumonitis With Trastuzumab Deruxtecan Treatment of Breast Cancer in European Countries: Results and Learnings From a Post-Authorization Safety Survey Among Physicians.

Angelika Wientzek-Fleischmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.